Varian Medical Systems Inc. | Income Statement

Fiscal year is October-September. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,940
3,049
3,095
2,622
2,668
2,920
Cost of Goods Sold (COGS) incl. D&A
1,636
1,696
1,766
1,462
1,466
1,590
Gross Income
1,305
1,352
1,330
1,160
1,203
1,330
SG&A Expense
641
706
745
668
737
793
EBIT
606
594
534
-
419
482
Unusual Expense
2
20
11
10
77
39
Non Operating Income/Expense
3
2
4
1
-
1
Interest Expense
4
7
8
12
11
7
Pretax Income
612
575
555
441
345
452
Income Tax
174
171
143
115
88
302
Consolidated Net Income
438
404
412
325
257
150
Net Income
438
404
411
325
257
150
Net Income After Extraordinaries
438
404
411
249
263
150
Net Income Available to Common
438
404
411
402
250
150
EPS (Basic)
3.98
3.83
4.09
4.19
2.68
1.62
Basic Shares Outstanding
108
104
100
95
93
92
EPS (Diluted)
3.98
3.83
4.09
4.19
2.68
1.62
Diluted Shares Outstanding
110
105
101
96
93
93
EBITDA
669
657
603
515
489
555
Other Operating Expense
58
52
51
46
47
56
Non-Operating Interest Income
7
11
14
17
14
17
Minority Interest Expense
-
-
1
-
1
-
Equity in Affiliates (Pretax)
-
3
1
-
-
-

About Varian Medical Systems

View Profile
Address
3100 Hansen Way
Palo Alto California 94304
United States
Employees -
Website http://www.varian.com
Updated 07/08/2019
Varian Medical Systems, Inc. engages in the manufacture of medical devices and software for treating cancer and other medical conditions. It operates through the Oncology Systems and Varian Particle Therapy segments. The Oncology Systems segment designs, manufactures, sells, and services hardware and software products for treating cancer with conventional radiation therapy, and advanced treatments.